Clever Fermentation
The Future of Metabolic Health

We like to think that eating whole foods is enough to keep us healthy. But research tells a more sobering story. Only about 10 percent of polyphenols—the antioxidant compounds found in foods and particularly in fruits—are actually absorbed by the body in their natural state.

According to Clever Fermentation’s Founder and CEO Sean Sears, this widening gap between what we consume and what our bodies can absorb signals a deeper systemic failure within our bodies.

“Our metabolic machinery is broken,” says Sears.

“You can eat a cup of fruit thinking you’re feeding your body antioxidants. But in truth, you might be absorbing less than 1.0 percent.”

The root of the issue lies in what modern diets have left behind. As fermented foods vanished from our plates, often replaced with processed foods, so did the microbial diversity our bodies once relied on to process food compounds. The enzymes and bacterial microbes required to unlock the most beneficial compounds, like polyphenols, are no longer reliably present in the gut. And without them, the body struggles to make use of even the healthiest foods.

Metabolic dysfunction has reached epidemic proportions today, affecting more than 85 percent of adults in the U.S, with 40 percent being insulin resistant.

This is the problem Clever Fermentation set out to solve.

For the past decade, Clever has been rethinking what nutrition can look like in a world where gut health is no longer a given. That work led to Bluotic, the world’s first tribiotic, a formulation that combines distinct types of microbiome-supportive components found in probiotics, prebiotics and postbiotics.

Instead of relying on the gut to break down complex polyphenols, Bluotic uses a proprietary multi-step fermentation process to pre-convert the fruit polyphenol into a broad array of the same bioactives the body creates through digestion. Combining carefully selected strains of probiotic bacteria and yeast mimics a healthy microbiome's metabolic work. It produces phenolic metabolites and short-chain fatty acids, critical bioactives the body can more easily use and that don’t need to be unlocked once they’re inside you.

Clever has spent years perfecting a formula designed for targeted colon delivery. This enables enhanced bioavailability as these phenolic metabolites arrive where they’re most needed, helping regulate immune function, lower inflammation and support brain health.

Bluotic is a huge biotechnological leap into the future of personalized nutrition. It’s Clever’s response to the question: What if we could make food smarter before it even reaches the fork?

Sparking a Scientific Shift

Clever’s breakthrough started in a wine cellar in Nova Scotia. Sears had recently acquired a winery when he stumbled upon an 8-year-old red that was peculiar. It no longer contained alcohol, and had an off expression. Anyone who drank it experienced a surprising and sustained sense of well-being. Puzzled, Sears sent it for testing. The results revealed a different kind of fermentation had occurred, one that had transformed the fruit’s polyphenols into beneficial bioactive compounds.

“I kept asking myself, what is this stuff and how do I make more of it?” Sears recalls.

That question became the seed of a scientific journey. Sears partnered with Dr. Vasantha Rupasinghe, a leading researcher at Dalhousie University known for his work on polyphenols, particularly those found in wild blueberries and their potential to support metabolic and cognitive health. After four years of collaborative research, Clever Fermentation officially launched in 2017.

The choice of fruit wasn’t random either. Wild blueberries, the world’s #1 superfruit, from Nova Scotia, are among the most polyphenol-dense fruits in the world. Celebrated for their high concentration of antioxidant compounds believed to protect against inflammation, oxidative stress and chronic disease. But there was a catch. Most of their therapeutic potential is lost during digestion.

Clever’s designed a fermentation process to change that. By replicating the enzymatic activity of a healthy microbiome, it preserves the intricate chemistry of the fruit while transforming its polyphenols. They choose the opposite of a concentrate. Their Intelligent Fermentation Platform design produces a broad array of beneficial bioactives that act together as the sum of the whole to deliver the benefits of one of nature’s most potent elixirs. And from that point forward, there has been no looking back for Clever.

Fermentation, Engineered for Impact

Most consumers assume that if a supplement label lists polyphenols, the benefits follow. But that’s rarely the case, especially when those compounds aren’t bioavailable in the first place. Clever set out to close that gap by delivering ingredients that are measurable, predictable and biologically meaningful.

Clever’s fermentation biotransforms superfruit polyphenols into a natural biology the body can immediately recognize and use. Preclinical data support this approach. In internal absorption models, Clever’s fermented ingredients consistently outperform standard fruit extracts, both in bioavailability and biological activity, indicating measurable gains in efficacy.

Now, the company is scaling its product pipeline. Its vision includes developing ten fermented superfruit nutraceuticals, each tailored to address a global metabolic health challenge from insulin resistance to cognitive decline. The early results are promising and Clever is expanding the platform to explore designer metabolite arrays for broader indications, including obesity and overall metabolic resilience.

And it is doing so with sustainability in mind. Globally, up to 25 percent of fruit is discarded before it ever reaches the market, rejected for cosmetic imperfections or surplus volume. Yet this so-called “waste” is often even richer in polyphenols than its retail-grade counterparts. Clever sees opportunity in what others overlook. By applying fermentation-based bioprocessing, the company transforms fruit “farm loss” into shelf-stable, high-impact health ingredients, expanding access to nutrition while actively reducing food waste.

In Tasmania, that vision is already being put into practice.

The island state is known for its high-quality fruit production and closed-loop circular economy agricultural systems. A recent government-backed fruit waste study yielded a surprising insight. Much of what’s classified as “waste” by processors isn’t waste to farmers at all. It’s just excess harvest that’s equally nutrient-dense and visually imperfect fruit that never made it to market.

In response, Tasmania launched FermenTasmania, a community bioprocessing hub created in part to repurpose surplus fruit, particularly polyphenol-rich varieties like apples, grapes and cherries, into next-generation health ingredients. Clever was a study participant, invited to contribute its fermentation technology to help bring this vision to life.

“It’s not just about preventing waste & lowering greenhouse gases,” Dr. Rupasinghe, Clever’s science advisor, explains. “It’s about rescuing value and turning what’s overlooked into something biologically meaningful. That wild blueberry ferment we’re preparing for a clinical trial in 2026 is more than a product. It’s a proof point for a new model of food, health and sustainability.”

This project hints at Clever’s broader ambition of closing the loop between agricultural oversupply and human nutritional gaps and doing so in a way that supports ecological resilience.

Where Innovation Meets the Future of Functional Health

Clever solves a real problem for today’s nutraceutical, functional food and wellness brands. As the market shifts toward science-backed natural products, companies are under pressure to deliver more than clean labels. They need proof that their ingredients have clinical depth and functional credibility.

That’s where Clever comes to their rescue. Its fermented compounds aren’t just shelf-stable or regulatory-friendly. They are designed to perform. Supplying pre-converted, ready-to-use biotic formulations empowers product developers to launch confidently, knowing their claims are backed by biological efficacy and emerging data.

“We’re not here to just supply ingredients. We’re here to deliver health outcomes that consumer manufacturers’ product teams can trust,” says Sears. “Whether supporting cognitive health, reducing inflammation or improving microbiome balance, our formulations are designed to deliver measurable, category-defining results.”

And that promise is only growing stronger. With AI and synthetic biology shaping its next chapter, the company is moving toward a future where fermentation microbes are custom-designed to produce targeted health outcomes. That means, soon, clients won’t just be sourcing a blueberry extract or cherry ferment. They’ll ask for a purpose-built solution to meet a specific metabolic or microbiome need.

By 2027, the company plans to scale Bluotic production and expand its portfolio with new fermented ingredients derived from other high-impact superfruits. Currently, developing a single ingredient takes roughly 18 months. But with the integration of AI-driven strain design and predictive health modelling, that timeline is expected to shorten significantly, opening the door to faster, more tailored innovation and true co-creation with clients.

As Clever prepares for clinical trials focused on cognitive health and moves toward full-scale manufacturing, its long-term vision is coming into clearer focus. For nutraceutical brands, this signals a shift in how partnerships are formed toward a model rooted in transparency, backed by data and driven by a shared belief that functional ingredients shouldn’t just read well on a label—they should deliver real, measurable impact.